Friday, 8 March 2019
And yet, it moves!
Blog posted by Professor Frank Van den Heuvel, Radiation Therapy Medical Physics Group Leader Galileo is said to have muttered ‘E pur, si muove!’ – ‘And yet, it moves’ as he left the courtroom in which he had been forced to concede that the sun moved round a fixed earth. Today, these words could be...
Thursday, 28 February 2019
No cure for cancer; just cures
Blog posted by Sophie Bowlzer, Clinical Trials Monitor in the Oncology Clinical Trials Office (OCTO) The cure for cancer, often hailed as the holy grail of medical research; something everyone is searching for and no one is finding, doesn’t actually exist. The idea that someone in a lab someday...
Tuesday, 12 February 2019
Study suggests immune system plays key role in survival after pancreatic cancer surgery
Study suggests immune system plays key role in survival after pancreatic cancer surgery 12 February 2019: Researchers in Oxford have found that an individual’s immune system – and in particular the presence of T-cells amongst tumour cells - may play an important role in survival after surgery to...
Thursday, 7 February 2019
10-Year Partnership with Genesis Care
GenesisCare and the University of Oxford establish innovative 10-year research partnership to improve diagnosis and care for people with cancer. 7 February 2019: Today GenesisCare and the University of Oxford’s Department of Oncology announce the launch of an exclusive 10-year partnership to...
Monday, 4 February 2019
The Researcher and the Frog
Readers will remember the blog from Timo Reislander, who wrote about his time spent with the FROG group; in this guest blog we hear from Jean, Co-ordinator of the FROG Blog posted by Jean Simmons, Co-ordinator of FROG – Friends of Renal Oncology Group Timo’s posting shows that his visit to FROG...
Thursday, 24 January 2019
Calculating age with DNA
Blog posted by: Hira Javaid, DPhil student How would you react if I told you I could calculate your age if I took a sample of your blood? I wouldn’t be lying! Every day our cells are exposed to damaging agents that can cause harmful changes which accumulate over time and lead to ageing related...
Thursday, 24 January 2019
New Director of the MRC Oxford Institute for Radiation Oncology
The Department of Oncology is pleased to announce that Professor Amato J Giaccia has been appointed as the new Director of the MRC Oxford Institute for Radiation Oncology (OIRO). Professor Giaccia joins the Department after many successful years as Director of the Division of Radiation & Cancer...
Wednesday, 9 January 2019
Engaging the public is not just for researchers
Blog posted by: Jackie Parker, Accounts Officer Researchers are always encouraged to reach out and tell the story of their work outside the University. Researchers should not have all the fun! Although I currently work in Accounts, my degree is in Human Biology. Once a scientist always a scientist...
Tuesday, 18 December 2018
Professor Sir David Weatherall
Blog posted by: Professor Adrian Harris, Group Leader in the Department of Oncology I was a Final Year medical student when David Weatherall was appointed Professor of Haematology in Liverpool University in 1973. He was an outstanding Lecturer, extremely popular with the students and helped to...
Friday, 30 November 2018
Characterising an insulin-like growth factor (IGF) signature for early detection/risk reduction of cancer
Researchers in the Department of Oncology have secured funding to characterise an insulin-like growth factor (IGF) signature for early detection and risk reduction of cancer. Dr Valentine Macaulay and Dr Guillaume Rieunier have been awarded a 3-year CRUK Early Detection project grant (~£400k) to...
Monday, 26 November 2018
News coverage for Drs Kerry Fisher and Joshua Freedman
Research by Dr Kerry Fisher and Dr Joshua Freedman was covered by The Independent and The Sun on 19 November. One of the problems we face in killing tumours is that the tumours often recruit healthy cells to help them grow and to protect them from attack. In this case tumours often recruit...
Tuesday, 20 November 2018
Cancer Immunologists Win Nobel Prize in Medicine
Blog posted by: Eleanor Scott, DPhil student Researchers James Allison and Tasuku Honjo have won the 2018 Nobel Prize in Medicine or Physiology for their pioneering work on cancer immunotherapy. Hailed as a revolution in the treatment of cancer, immunotherapy works by boosting the body’s natural...
Friday, 9 November 2018
Employer Award from Science Oxford
The Department of Oncology has been awarded a Bronze Employer Award from Science Oxford for our contributions to STEM week in 2018. Engaging young people with our science provides a valuable link between their school studies and the real-world uses of science. We were able to help students...
Tuesday, 6 November 2018
Oxford secures Innovate UK funding to use AI to improve diagnosis
Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), will confirm today (Tuesday 6 November) that UK Research and Innovation will invest £10million in the National Consortium of Intelligent Medical Imaging (NCIMI), to be led from Oxford University as part of the...
Tuesday, 9 October 2018
Entering a world of computer powered research - 176 years after Ada Lovelace
Blog posted by: Sylvana Hassanieh, DPhil student In October 1843 Ada Lovelace published a set of notes which included a description of an algorithm to compute Bernoulli numbers on Charles Babbage’s analytical engine. Ada Lovelace Day in early October celebrates the achievements of women in science...
Monday, 1 October 2018
Andrew Blackford and Simon Lord become the first Against Breast Cancer Research Fellows at Oriel College
Wednesday, 12 September 2018
UNIQ Summer School - practical tutoring through the eyes of a DPhil student
Tuesday, 10 July 2018
Focussed ultrasound and nanomedicine offer new hope for improving effects of cancer drugs.
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.